CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 8-K Event Executive or director change
- 4 Grant or award EVP, Chief Financial Officer acquired 374,891 shares (grant or award)
- 4 Grant or award EVP, General Counsel acquired 287,707 shares (grant or award)
- 4 Grant or award SVP, Controller & CAO acquired 34,873 shares (grant or award)
- 4 Returned to the company Chief Executive Officer returned 15,389 shares (to the company)
- 10-Q/A Report 10-Q/A
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 4/A Grant or award Director acquired 4,314 shares (grant or award)
- 4 Grant or award Director acquired 2,251 shares (grant or award)
- 4 Grant or award Director acquired 4,560 shares (grant or award)
- 4 Grant or award Director acquired 822 shares (grant or award)
- 4 Grant or award Director acquired 3,663 shares (grant or award)
- 4 Grant or award Director acquired 3,663 shares (grant or award)
- 4 Grant or award Director acquired 4,111 shares (grant or award)
Page 17 of 121 · 2,419 filings